Xcout Intel
Elevar Therapeutics
Elevar Therapeutics is a fully integrated biopharmaceutical company founded in 2019 that focuses on elevating treatment experiences and patient outcomes.
Subscribe to see Elevar Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Elevar Therapeutics at a glance
Elevar Therapeutics is a healthcare company headquartered in United States. Xcout tracks 13 named people at Elevar Therapeutics, including Dong-Gun Kim (Chief Executive Officer).
Elevar Therapeutics leadership
- Dong-Gun KimChief Executive Officer
- Chul-Woong ParkChief Financial Officer & Corporate Secretary
- Yang Gon JinChairman of the Board
- Dominick DiPaoloSVP, Quality & Drug Safety
- Michael PaluckiSVP, Manufacturing
- Rose LaiSVP, Clinical Development Oncology
7 more named people on record for Elevar Therapeutics, with roles, board committees and tenure — see the full roster →
Elevar Therapeutics competitors
A few of Elevar Therapeutics's closest competitors — see the full list of competitors and alternatives →
Connect Biopharmaceuticals is a biopharmaceutical company headquartered in Taicang, China, founded in 2012 to develop novel treatments.
Spot Biosystems is a gene therapy company pioneering a novel non-viral extracellular delivery approach. Headquartered in Palo Alto, California, the company launched with significant financing to advance its therapeutic pipeline.
Oruka Therapeutics, Inc. is a biopharmaceutical company dedicated to developing novel biologics designed to establish a new treatment standard for chronic skin diseases.
Equator Therapeutics is a privately held biotechnology company headquartered in San Francisco, California. The company leverages recent scientific breakthroughs to enable the pharmacological stimulation of thermogenesis for achieving sustained weight loss.
ElevateBio is a biotechnology company that builds and operates cell and gene therapy companies and provides development, manufacturing, and technology capabilities through its platform, including BaseCamp. It serves biotech and pharmaceutical organizations developing advanced therapies, as well as supporting the creation of new therapeutic companies.
Avalor Therapeutics, Inc. is a biotechnology company focused on the research and development of novel therapeutic products to address unmet medical needs for patients. The company builds its pipeline through scientific research and teamwork.
Get Elevar Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Elevar Therapeutics in Xcout Intel
- 13 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access